Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia

By Valero M.V.   Amador R.   Aponte J.J.   Narvaez A.   Galindo C.   Silva Y.   Rosas J.   Guzman F.   Patarroyo M.E.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1466-1470

Elsevier

Access to resources Recommend Favorite

The effect of temperature on the stability of the synthetic SPf(66)n malaria vaccine

By Lopez M.C.   Thomas M.C.   Olivares M.   Alonso P.   Alonso C.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1180-1182

Elsevier

Access to resources Recommend Favorite

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

By Liao S.-s.   Li R.-c.   Li H.   Yang J.-y.   Zeng X.-j.   Gong J.   Wang S.-s.   Li Y.-p.   Zhang K.-l.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2661-2666

Elsevier

Access to resources Recommend Favorite

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

By Kashala O.   Amador R.   Valero M.V.   Moreno A.   Barbosa A.   Nickel B.   Daubenberger C.A.   Guzman F.   Pluschke G.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2263-2277

Elsevier

Access to resources Recommend Favorite

Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66

By Rosas J.E.   Hernandez R.M.   Gascon A.R.   Igartua M.   Guzman F.   Patarroyo M.E.   Pedraz J.L.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4445-4451

Elsevier

Access to resources Recommend Favorite